Lipofundin 20% induces hepatic lipid peroxidation in New Zealand white rabbits

Lipofundin 20% induces hepatic lipid peroxidation in New Zealand white rabbits

ABSTRACT

Objective. The aim of the present work was to evaluate the effects of Lipofundin 20% on lipid peroxidation markers in the liver of New Zealand white rabbits. Materials and methods. The animals were treated with an intravenous injection (2 ml/kg) of the lipid emulsion during 8 days through the marginal ear vein. At the end of the experiment some lipid peroxidation parameters and lipid profile were tested through spectrophotography. Results. Lipofundin was found to induce a significant (p<0.05) increase of malondialdehyde, total hydroperoxides, and peroxidation potential. Also, high levels of total cholesterol, triglycerides, LDL - cholesterol and HDL-cholesterol were observed in treated animals compared with the control group (p<0.05). Conclusions. Data proved that Lipofundin induces hepatic lipid peroxidation in rabbits, mainly through a mechanism which involves an induction of hyperlipidemia

1. Niki E. Free radicals in the 1900's: from in vitro to in vivo. Free Radic Res 2000; 33:693-704. http://dx.doi.org/10.1080/10715760000301221
3. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009; 47:469-484. http://dx.doi.org/10.1016/j.freeradbiomed.2009.05.032
5. Dalle-Donne I, Rossi R, Colombo R, Gustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52: 601-623. http://dx.doi.org/10.1373/clinchem.2005.061408
7. Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta 2001; 306: 1-17. http://dx.doi.org/10.1016/S0009-8981(01)00393-X
9. Hailer S, Wolfram G. Influence of artificial fat emulsions on the composition of serum lipoproteins in humans. Am J Clin Nutr 1986; 43:225-233.
11. Calder PC, Jensen GL, Koletsko BV, Singer P, Wanten GJA. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med 2010; 36:735-749. http://dx.doi.org/10.1007/s00134-009-1744-5
13. Delgado L, Acosta E, Fraga A, Bécquer MA, Soto Y, Cama V et al. Lipofundininduce hyperlipidemia promotes oxidative stress and atherosclerotic lesions in New Zealand White rabbits. Int J Vasc Med 2011; 2012:1-7. http://dx.doi.org/10.1155/2012/898769
15. Delgado L, Acosta E, Hernández-Matos Y, Bécquer MA, Vázquez AM, FernándezSánchez E. High levels of lipid peroxidation induced by Lipofundin administration correlates with atherosclerotic lesions in rabbits. Pharmacol online 2010; 3:727-736.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254. http://dx.doi.org/10.1016/0003-2697(76)90527-3
19. Erdelmeier I, Gerard-Monnier D, Yadan JC, Chaudiere J. Reactions of N-methyl- 2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem Res Toxicol 1998; 11:1184-1194. http://dx.doi.org/10.1021/tx970180z
21. Ozdemirler G, Mehmetcik G, Oztezcan S, Toker G, Sivas A, Uysal M. Peroxidation potential and antioxidant activity of serum in patients with diabetes mellitus and myocardial infarction. Horm Metab Res 1995; 27:194-196. http://dx.doi.org/10.1055/s-2007-979938
23. Jain KS, Kathiravan MK, Somani RS, Shishoo CJ. The biology and chemistry of hyperlipidemia. Bioorg Med Chem 2007; 15:4674-4699. http://dx.doi.org/10.1016/j.bmc.2007.04.031
25. Carlson LA. Studies on the fat emulsion Intralipid®. I. Association of serum protein to Intralipid® triglycerides particle. Scand J Clin Lab Invest 1980; 40:139-144.
27. Horwich TB, Hernández AF, Dai D, Yancy CW, Fonarow GC. Cholesterol levels and in-hospital mortality in patients with acute decompensate heart failure. Am Heart J 2008; 156:1170-1176. http://dx.doi.org/10.1016/j.ahj.2008.07.004
29. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 2006; 8:1865-1879. http://dx.doi.org/10.1089/ars.2006.8.1865
31. Richard D, Kefi K, Barbe U, Bausero P, Visioli F. Polyunsaturated fatty acids as antioxidants. Pharmacol Res 2008; 57:451-455. http://dx.doi.org/10.1016/j.phrs.2008.05.002
33. Delgado L, Fraga A, Bécquer MA, HernándezMatos Y. Lipofundin induces hyperlipidemia and oxidative stress in male Sprague Dawley rats. Vet World 2012; 5:133-137. http://dx.doi.org/10.5455/vetworld.2012.133-137.
35. Leonarduzzi G, Chiarpotto E, Biasi F, Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 2005; 49:1044-1049. http://dx.doi.org/10.1002/mnfr.200500090
37. Greenberg ME, Li XM, Gugiu BG, Gu X, Qin J, Salomon RG et al. The lipid whisker model of the structure of oxidized membranes. J Biol Chem 2008; 283:2385-2396. http://dx.doi.org/10.1074/jbc.M707348200
39. Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Fuji T et al. Association of plasma level of malondialdehyde-modified lowdensity lipoprotein with coronary spastic angina: implication of acute coronary events. Int J Cardiol 2009; 135:202-206. http://dx.doi.org/10.1016/j.ijcard.2008.03.071
41. Tavori H, Aviram M, Khatib S, Musa R, Nitecki S, Hoffman A et al. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low density lipoproteins, whereas paraoxonase (PON1) decreases such atherogenic effects. Free Radic Biol Med 2009; 46:607-615. http://dx.doi.org/10.1016/j.freeradbiomed.2008.11.019